ERBB2 and neoplasm: In addition, Shoda et al. [55] reported on potential of ctDNA for the detection of HER2 amplification determined by real-time quantitative PCR (qRT-PCR) in AGC patients before surgery and during postoperative treatment, highlighting spatial and/or temporal tumor heterogeneities.